BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9220592)

  • 1. Functional aspects of Aujeszky's disease (pseudorabies) viral proteins with relation to invasion, virulence and immunogenicity.
    Nauwynck HJ
    Vet Microbiol; 1997 Apr; 55(1-4):3-11. PubMed ID: 9220592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.
    Jacobs L
    Arch Virol; 1994; 137(3-4):209-28. PubMed ID: 7944945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudorabies (Aujeszky's disease) virus: state of the art. August 1993.
    Mettenleiter TC
    Acta Vet Hung; 1994; 42(2-3):153-77. PubMed ID: 7810409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aujeszky's disease (pseudorabies) virus eradication campaign in The Netherlands.
    Stegeman A
    Vet Microbiol; 1997 Apr; 55(1-4):175-80. PubMed ID: 9220611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tests for detection of antibodies to Aujeszky's disease (pseudorabies) virus glycoprotein E in the target population.
    Stegeman A; De Jong MC; Van der Heijden HM; Elbers AR; Kimman TG
    Vet Microbiol; 1997 Apr; 55(1-4):107-11. PubMed ID: 9220602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of pseudorabies (Aujeszky's disease) virus.
    Mettenleiter TC
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):151-63. PubMed ID: 1657509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in latency and recombination of Aujeszky's disease (pseudorabies) virus.
    Maes RK; Sussman MD; Vilnis A; Thacker BJ
    Vet Microbiol; 1997 Apr; 55(1-4):13-27. PubMed ID: 9220593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence.
    Gerdts V; Beyer J; Lomniczi B; Mettenleiter TC
    J Virol; 2000 Jan; 74(2):817-27. PubMed ID: 10623744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus.
    Visser N
    Vet Microbiol; 1997 Apr; 55(1-4):61-74. PubMed ID: 9220597
    [No Abstract]   [Full Text] [Related]  

  • 14. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.
    Vannier P; Hutet E; Bourgueil E; Cariolet R
    Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.
    van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP
    Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host.
    Dijkstra JM; Gerdts V; Klupp BG; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2147-51. PubMed ID: 9292000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with recombinant vaccinia virus vaccines expressing glycoprotein genes of pseudorabies virus in the presence of maternal immunity.
    Brockmeier SL; Lager KM; Mengeling WL
    Vet Microbiol; 1997 Nov; 58(2-4):93-103. PubMed ID: 9453121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs.
    Vanderpooten A; Goddeeris B; De Roose P; Hendrickx L; Biront P; Desmettre P
    Vet Microbiol; 1997 Apr; 55(1-4):81-9. PubMed ID: 9220599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine.
    Asai T; Tajima M; Watanabe H; Shibata I
    J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
    Ishii H; Kobayashi Y; Kuroki M; Kodama Y
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.